An improved Tet-On regulatable FasL-adenovirus vector system for lung cancer therapy

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of molecular medicine

• Publication date

  2006-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00109-005-0009-1PMID 16437213
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tamoxifen-regulated adenoviral E1A chimeras for the control of tumor selective oncolytic adenovirus replication in vitro and in vivo

  2006cited by this paper
• Viral and nonviral factors causing nonspecific replication of tumor- and tissue-specific promoter-dependent oncolytic adenoviruses.

  2005cited by this paper
• New complex Ad vectors incorporating both rtTA and tTS deliver tightly regulated transgene expression both in vitro and in vivo

  2005cited by this paper
• Regulated and constitutive expression of anti-inflammatory cytokines by nontransforming herpesvirus saimiri vectors

  2005cited by this paper
• Tight control of transgene expression by lentivirus vectors containing second‐generation tetracycline‐responsive promoters

  2005cited by this paper
• Cyclooxygenase as a Target in Lung Cancer

  2004cited by this paper
• Gene therapy platform for bone regeneration using an exogenously regulated, AAV-2-based gene expression system.

  2004cited by this paper
• Second‐generation tetracycline‐regulatable promoter: repositioned tet operator elements optimize transactivator synergy while shorter minimal promoter offers tight basal leakiness

  2004influential reference
• Construction of an rtTA2s-m2/ttskid-Based transcription regulatory switch that displays no basal activity, good inducibility, and high responsiveness to doxycycline in mice and Non-Human primates

  2003cited by this paper
• Tight Positive Regulation of Transgene Expression by a Single Adenovirus Vector Containing the rtTA and tTS Expression Cassettes in Separate Genome Regions

  2003influential reference
• A novel tetracycline-controlled transactivator–transrepressor system enables external control of oncolytic adenovirus replication

  2003cited by this paper
• CD95/Fas signaling in human melanoma cells: conditional expression of CD95L/FasL overcomes the intrinsic apoptosis resistance of malignant melanoma and inhibits growth and progression of human melanoma xenotransplants

  2003cited by this paper
• Regulation of human factor IX expression using doxycycline-inducible gene expression system

  2003cited by this paper
• Quantification and characterization of the bystander effect in prostate cancer cells following adenovirus-mediated FasL expression

  2003cited by this paper
• Construction of an rtTA2(s)-m2/tts(kid)-based transcription regulatory switch that displays no basal activity, good inducibility, and high responsiveness to doxycycline in mice and non-human primates.

  2003cited by this paper
• Adeno-associated virus terminal repeat (TR) mutant generates self-complementary vectors to overcome the rate-limiting step to transduction in vivo

  2003cited by this paper
• A system for small-molecule control of conditionally replication-competent adenoviral vectors.

  2002cited by this paper
• Tight control of gene expression by a helper-dependent adenovirus vector carrying the rtTA2s-M2 tetracycline transactivator and repressor system

  2002cited by this paper
• Tissue-Specific, Tumor-Selective, Replication-Competent Adenovirus Vector for Cancer Gene Therapy

  2001cited by this paper
• Manipulation of gene expression by an ecdysone-inducible gene switch in tumor xenografts

  2001cited by this paper
• Trans-complementation of vector replication versus Coxsackie-adenovirus-receptor overexpression to improve transgene expression in poorly permissive cancer cells

  2000cited by this paper
• Analysis of Fas and Fas ligand expression and function in lung cancer cell lines.

  2000cited by this paper
• Intracellular Fas ligand expression causes Fas-mediated apoptosis in human prostate cancer cells resistant to monoclonal antibody-induced apoptosis.

  2000cited by this paper
• Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity.

  2000cited by this paper
• Molecular and genetic aspects of lung cancer.

  2000cited by this paper
• The tetracycline-responsive promoter contains functional interferon-inducible response elements.

  2000cited by this paper
• A tetracycline controlled activation/repression system with increased potential for gene transfer into mammalian cells

  1999cited by this paper
• ‘Autoreplication’ of the vector genome in recombinant adenoviral vectors with different E1 region deletions and transgenes

  1999cited by this paper
• Adenovirus-mediated expression of Fas ligand induces apoptosis of human prostate cancer cells

  1999cited by this paper
• Establishment and Characterization of an Immortalized Human Sebaceous Gland Cell Line (SZ95)1

  1999cited by this paper
• Establishment and characterization of an immortalized human sebaceous gland cell line (SZ95).

  1999cited by this paper
• Lack of cell surface Fas/APO-1 expression in pulmonary adenocarcinomas.

  1998cited by this paper
• Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer

  1998cited by this paper
• Apoptosis by Retrovirus- and Adenovirus-Mediated Gene Transfer of Fas Ligand to Glioma Cells: Implications for Gene Therapy

  1998cited by this paper
• Transcriptional activation by tetracyclines in mammalian cells.

  1995cited by this paper
• Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule.

  1994cited by this paper
• Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.

  1992cited by this paper

• Immortalization Reversibility in the Context of Cell Therapy Biosafety

  2023cites this paper
• Cell Immortalization: In Vivo Molecular Bases and In Vitro Techniques for Obtention

  2023cites this paper
• Oncolytic viruses in lung cancer treatment: a review article.

  2023cites this paper
• A prospect of cell immortalization combined with matrix microenvironmental optimization strategy for tissue engineering and regeneration

  2019cites this paper
• Construction and characterization of regulated cycle inhibiting factors induced upon Tet-On system in human colon cancer cell lines

  2018cites this paper
• RNA-Interferenz-basierte Therapien bei Adenovirusinfektionen im immunsupprimierten Wirt

  2017cites this paper
• Adenoviral Vector Construction I

  2016cites this paper
• CD95 signaling in cancer treatment.

  2014cites this paper
• Functional investigation of Fas ligand expressions in human non-small cell lung cancer cells and its clinical implications.

  2013cites this paper
• Construction and Expression of an Eukaryotic Expression Vector Containing the IER 3 Gene

  2013cites this paper
• Construction and expression of an eukaryotic expression vector containing the IER3 gene.

  2013cites this paper
• Genomics and Systems Biology of Mammalian Cell Culture

  2012cites this paper
• Targeting the Fas/FasL signaling pathway in cancer therapy

  2012cites this paper
• Inducible immortality in hTERT‐human mesenchymal stem cells

  2012cites this paper
• Genetic aspects of cell line development from a synthetic biology perspective.

  2012cites this paper
• Efficient Melanoma Cell Killing and Reduced Melanoma Growth in Mice by a Selective Replicating Adenovirus Armed with Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand

  2011cites this paper
• Gene Switches for Deliberate Regulation of Transgene Expression: Recent Advances in System Development and Uses

  2011cites this paper
• Ex vivo Lung Perfusion: A Platform for Lung Evaluation and Repair

  2011cites this paper
• Functional identification of optimized RNAi triggers using a massively parallel sensor assay.

  2011cites this paper
• Tuning and controlling gene expression noise in synthetic gene networks

  2010cites this paper
• Promoter control over foreign antigen expression in a murine cytomegalovirus vaccine vector.

  2010cites this paper
• Efficient and selective tumor cell lysis and induction of apoptosis in melanoma cells by a conditional replication‐competent CD95L adenovirus

  2009cites this paper
• Prevention of Cardiac Dysfunction in Acute Coxsackievirus B3 Cardiomyopathy by Inducible Expression of a Soluble Coxsackievirus-Adenovirus Receptor

  2009cites this paper
• The role of FasL and Fas in health and disease.

  2009cites this paper
• Therapeutic targets of the TNF superfamily

  2009cites this paper
• Combination of soluble coxsackievirus-adenovirus receptor and anti-coxsackievirus siRNAs exerts synergistic antiviral activity against coxsackievirus B3.

  2009cites this paper
• Optimierung und Charakterisierung des lentiviralen Gentransfers in humanen mesenchymalen Stammzellen

  2008cites this paper
• Novel strategies in tailoring human adenoviruses into therapeutic cancer gene therapy vectors

  2008cites this paper
• Intronically encoded siRNAs improve dynamic range of mammalian gene regulation systems and toggle switch

  2008cites this paper
• Anticancer activity of oncolytic adenovirus vector armed with IFN-α and ADP is enhanced by pharmacologically controlled expression of TRAIL

  2008cites this paper
• Turning the gene tap off; implications of regulating gene expression for cancer therapeutics

  2008cites this paper
• An Improved Tet-On System for Gene Expression in Neurons Delivered by a Single Lentiviral Vector

  2008cites this paper
• Inducibility of doxycycline-regulated gene in neural and neuroendocrine cells strongly depends on the appropriate choice of a tetracycline-responsive promoter.

  2008cites this paper
• A bidirectional Tet-dependent promotor construct regulating the expression of E1A for tight control of oncolytic adenovirus replication.

  2007cites this paper
• Coxsackievirus B3 and adenovirus infections of cardiac cells are efficiently inhibited by vector-mediated RNA interference targeting their common receptor

  2007cites this paper
• Gene therapy for Parkinson’s disease: current approaches and future directions

  2007cites this paper
• Functional analysis of ICAD-S protein and the development of a novel technology for site-specific protein cleavage in vertebrate cells.

  2007cites this paper
• Apoptosis pathways and oncolytic adenoviral vectors: promising targets and tools to overcome therapy resistance of malignant melanoma

  2007cites this paper
• Dimethyl sulfoxide enhances doxycycline-dependent protein expression in Tet-On cells.

  2007cites this paper
• Secretory expression of synthetic human Fas ligand extracellular domain gene in Pichia pastoris: influences of tag addition and N-glycosylation site deletion, and development of a purification method.

  2006cites this paper